Please assess the completion status of the following clinical trial:

Trial Title: Prophylactic Intra-coronary Adenosine to Prevent Post Coronary Artery Stenting Myonecrosis

Study Design Characteristics:
- Allocation: NON_RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE3
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Patients undergoing percutaneous coronary balloon angioplasty and stenting~* Ages 18 years and older~* TIMI III flow on the initial angiography~* Native coronary artery lesions~Exclusion Criteria:~* Patients unable to give consent~* Adenosine allergy~* Severe asthma with bronchial reactivity~* Cardiogenic or circulatory shock~* Acute or chronic total coronary artery occlusions~* Patients requiring Rotablator therapy~* In stent restenosis~* Second or third degree AV block without a permanent pacemaker~* ST-Elevation MI~* Elevated baseline CK/ CK-MB or troponin levels (Pre-existing Non-STemi)~* Current pregnancy~* Patients not already on statin therapy or intolerant of statins

- Gender: ALL
- Minimum Age: 18 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- 1 (Type: OTHER): Either Placebo or Adenosine mixed with normal saline at a concentration of 6 micrograms per milliliter.
- 2 (Type: OTHER): Either Placebo or Adenosine mixed with normal saline at a concentration of 6 micrograms per milliliter.

Based on this trial design, predict the completion outcome and termination type (if applicable).